Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael E Smith

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Vaccine|June 16, 2022
Vaccine-associated attenuation of subjective severity among outpatients with influenzaJessie R Chung, Sara S Kim, Brendan Flannery, et al.
Npj Urban Sustainability|June 16, 2023
Integration of urban science and urban climate adaptation research: opportunities to advance climate actionJosé Lobo, Rimjhim M Aggarwal, Marina Alberti, et al.
The Journal of Infectious Diseases|September 9, 2021
Messenger RNA Vaccine Effectiveness Against Coronavirus Disease 2019 Among Symptomatic Outpatients Aged ≥16 Years in the United States, February-May 2021Sara S Kim, Jessie R Chung, Edward A Belongia, et al.
Epidemics|January 17, 2026
Estimating influenza transmission parameters: Comparing two study designs, 2023-2024Jessica E Biddle, Stacey House, Jennie H Kwon, et al.
JMIR Research Protocols|October 18, 2021
Research on the Epidemiology of SARS-CoV-2 in Essential Response Personnel (RECOVER): Protocol for a Multisite Longitudinal Cohort StudyLaura J Edwards, Ashley L Fowlkes, Meredith G Wesley, et al.
MMWR. Morbidity and Mortality Weekly Report|April 1, 2021
Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers - Eight U.S. Locations, December 2020-March 2021Mark G Thompson, Jefferey L Burgess, Allison L Naleway, et al.
The New England Journal of Medicine|June 30, 2021
Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 VaccinesMark G Thompson, Jefferey L Burgess, Allison L Naleway, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Vaccine|June 16, 2022
Vaccine-associated attenuation of subjective severity among outpatients with influenzaJessie R Chung, Sara S Kim, Brendan Flannery, et al.
Npj Urban Sustainability|June 16, 2023
Integration of urban science and urban climate adaptation research: opportunities to advance climate actionJosé Lobo, Rimjhim M Aggarwal, Marina Alberti, et al.
The Journal of Infectious Diseases|September 9, 2021
Messenger RNA Vaccine Effectiveness Against Coronavirus Disease 2019 Among Symptomatic Outpatients Aged ≥16 Years in the United States, February-May 2021Sara S Kim, Jessie R Chung, Edward A Belongia, et al.
Epidemics|January 17, 2026
Estimating influenza transmission parameters: Comparing two study designs, 2023-2024Jessica E Biddle, Stacey House, Jennie H Kwon, et al.
JMIR Research Protocols|October 18, 2021
Research on the Epidemiology of SARS-CoV-2 in Essential Response Personnel (RECOVER): Protocol for a Multisite Longitudinal Cohort StudyLaura J Edwards, Ashley L Fowlkes, Meredith G Wesley, et al.
MMWR. Morbidity and Mortality Weekly Report|April 1, 2021
Interim Estimates of Vaccine Effectiveness of BNT162b2 and mRNA-1273 COVID-19 Vaccines in Preventing SARS-CoV-2 Infection Among Health Care Personnel, First Responders, and Other Essential and Frontline Workers - Eight U.S. Locations, December 2020-March 2021Mark G Thompson, Jefferey L Burgess, Allison L Naleway, et al.
The New England Journal of Medicine|June 30, 2021
Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 VaccinesMark G Thompson, Jefferey L Burgess, Allison L Naleway, et al.
Pageof 8